Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer.
Thomas A, Reetz S, Stenzel P, Tagscherer K, Roth W, Schindeldecker M, Michaelis M, Rothweiler F, Cinatl J Jr, Cinatl J, Dotzauer R, Vakhrusheva O, Albersen M, Macher-Goeppinger S, Haferkamp A, Juengel E, Neisius A, Tsaur I. Thomas A, et al. Among authors: tsaur i. Cancers (Basel). 2021 May 12;13(10):2323. doi: 10.3390/cancers13102323. Cancers (Basel). 2021. PMID: 34066040 Free PMC article.
Nivolumab Reduces PD1 Expression and Alters Density and Proliferation of Tumor Infiltrating Immune Cells in a Tissue Slice Culture Model of Renal Cell Carcinoma.
Stenzel PJ, Hörner N, Foersch S, Wagner DC, Tsaur I, Thomas A, Haferkamp A, Macher-Goeppinger S, Roth W, Porubsky S, Tagscherer KE. Stenzel PJ, et al. Among authors: tsaur i. Cancers (Basel). 2021 Sep 8;13(18):4511. doi: 10.3390/cancers13184511. Cancers (Basel). 2021. PMID: 34572738 Free PMC article.
Value of c-MET and Associated Signaling Elements for Predicting Outcomes and Targeted Therapy in Penile Cancer.
Thomas A, Slade KS, Blaheta RA, Markowitsch SD, Stenzel P, Tagscherer KE, Roth W, Schindeldecker M, Michaelis M, Rothweiler F, Cinatl J, Dotzauer R, Vakhrusheva O, Albersen M, Haferkamp A, Juengel E, Cinatl J Jr, Tsaur I. Thomas A, et al. Among authors: tsaur i. Cancers (Basel). 2022 Mar 25;14(7):1683. doi: 10.3390/cancers14071683. Cancers (Basel). 2022. PMID: 35406455 Free PMC article.
CCL2 Chemokine as a Potential Biomarker for Prostate Cancer: A Pilot Study.
Tsaur I, Noack A, Makarevic J, Oppermann E, Waaga-Gasser AM, Gasser M, Borgmann H, Huesch T, Gust KM, Reiter M, Schilling D, Bartsch G, Haferkamp A, Blaheta RA. Tsaur I, et al. Cancer Res Treat. 2015 Apr;47(2):306-12. doi: 10.4143/crt.2014.015. Epub 2014 Oct 13. Cancer Res Treat. 2015. PMID: 25483747 Free PMC article.
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Gandaglia G, Briganti A, de Visschere P, Mathieu R, Valerio M, van den Bergh R, Ost P, Mirvald C, Tilki D, Ploussard G, Surcel C; EAU-YAU Prostate Cancer Working Party. Tsaur I, et al. Cancer Treat Rev. 2019 May;75:20-26. doi: 10.1016/j.ctrv.2019.03.001. Epub 2019 Mar 11. Cancer Treat Rev. 2019. PMID: 30875581 Review.
Use of psycho-oncological services by prostate cancer patients: A multilevel analysis.
Breidenbach C, Roth R, Ansmann L, Wesselmann S, Dieng S, Carl EG, Feick G, Oesterle A, Bach P, Beyer B, Borowitz R, Erdmann J, Kunath F, Oostdam SJ, Tsaur I, Zengerling F, Kowalski C. Breidenbach C, et al. Among authors: tsaur i. Cancer Med. 2020 Jun;9(11):3680-3690. doi: 10.1002/cam4.2999. Epub 2020 Mar 31. Cancer Med. 2020. PMID: 32233081 Free PMC article.
192 results